155 related articles for article (PubMed ID: 19896994)
1. The interferon antagonistic activities of the V proteins from two strains of Newcastle disease virus correlate with their known virulence properties.
Alamares JG; Elankumaran S; Samal SK; Iorio RM
Virus Res; 2010 Jan; 147(1):153-7. PubMed ID: 19896994
[TBL] [Abstract][Full Text] [Related]
2. The interferon antagonistic activities of the V proteins of NDV correlated with their virulence.
Wang X; Dang R; Yang Z
Virus Genes; 2019 Apr; 55(2):233-237. PubMed ID: 30706195
[TBL] [Abstract][Full Text] [Related]
3. Expression of interferon gamma by a highly virulent strain of Newcastle disease virus decreases its pathogenicity in chickens.
Susta L; Cornax I; Diel DG; Garcia SC; Miller PJ; Liu X; Hu S; Brown CC; Afonso CL
Microb Pathog; 2013; 61-62():73-83. PubMed ID: 23711962
[TBL] [Abstract][Full Text] [Related]
4. Immune responses of mature chicken bone-marrow-derived dendritic cells infected with Newcastle disease virus strains with differing pathogenicity.
Xiang B; Zhu W; Li Y; Gao P; Liang J; Liu D; Ding C; Liao M; Kang Y; Ren T
Arch Virol; 2018 Jun; 163(6):1407-1417. PubMed ID: 29397456
[TBL] [Abstract][Full Text] [Related]
5. Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy.
Elankumaran S; Chavan V; Qiao D; Shobana R; Moorkanat G; Biswas M; Samal SK
J Virol; 2010 Apr; 84(8):3835-44. PubMed ID: 20147405
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Newcastle disease virus (NDV) La Sota expressing the haemagglutinin-neuraminidase protein of genotype VII NDV shows improved protection efficacy against NDV challenge.
Bu YW; Yang HM; Jin JH; Zhao J; Xue J; Zhang GZ
Avian Pathol; 2019 Apr; 48(2):91-97. PubMed ID: 30465608
[TBL] [Abstract][Full Text] [Related]
7. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins.
Park MS; Shaw ML; Muñoz-Jordan J; Cros JF; Nakaya T; Bouvier N; Palese P; García-Sastre A; Basler CF
J Virol; 2003 Jan; 77(2):1501-11. PubMed ID: 12502864
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the contributions of individual viral genes to newcastle disease virus virulence and pathogenesis.
Paldurai A; Kim SH; Nayak B; Xiao S; Shive H; Collins PL; Samal SK
J Virol; 2014 Aug; 88(15):8579-96. PubMed ID: 24850737
[TBL] [Abstract][Full Text] [Related]
9. The large polymerase protein is associated with the virulence of Newcastle disease virus.
Rout SN; Samal SK
J Virol; 2008 Aug; 82(16):7828-36. PubMed ID: 18550657
[TBL] [Abstract][Full Text] [Related]
10. Newcastle disease virus V protein is a determinant of host range restriction.
Park MS; García-Sastre A; Cros JF; Basler CF; Palese P
J Virol; 2003 Sep; 77(17):9522-32. PubMed ID: 12915566
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Replication of Virulent Newcastle Disease Virus in Chicken Macrophages Is due to Polarized Activation of Cells by Inhibition of TLR7.
Zhang P; Ding Z; Liu X; Chen Y; Li J; Tao Z; Fei Y; Xue C; Qian J; Wang X; Li Q; Stoeger T; Chen J; Bi Y; Yin R
Front Immunol; 2018; 9():366. PubMed ID: 29670609
[TBL] [Abstract][Full Text] [Related]
12. Role of fusion protein cleavage site in the virulence of Newcastle disease virus.
Panda A; Huang Z; Elankumaran S; Rockemann DD; Samal SK
Microb Pathog; 2004 Jan; 36(1):1-10. PubMed ID: 14643634
[TBL] [Abstract][Full Text] [Related]
13. Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.
Huang Z; Krishnamurthy S; Panda A; Samal SK
J Virol; 2003 Aug; 77(16):8676-85. PubMed ID: 12885886
[TBL] [Abstract][Full Text] [Related]
14. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicity.
Samal S; Kumar S; Khattar SK; Samal SK
J Gen Virol; 2011 Oct; 92(Pt 10):2333-2338. PubMed ID: 21677091
[TBL] [Abstract][Full Text] [Related]
16. [Cytopathic effect of the Newcastle disease virus on the BHK-21 cell line].
Gerganov G; Surtmadzhiev K
Vet Med Nauki; 1978; 15(8):3-12. PubMed ID: 375573
[TBL] [Abstract][Full Text] [Related]
17. Generation of a velogenic Newcastle disease virus from cDNA and expression of the green fluorescent protein.
Liu YL; Hu SL; Zhang YM; Sun SJ; Romer-Oberdorfer A; Veits J; Wu YT; Wan HQ; Liu XF
Arch Virol; 2007; 152(7):1241-9. PubMed ID: 17393069
[TBL] [Abstract][Full Text] [Related]
18. Immune responses of poultry to Newcastle disease virus.
Kapczynski DR; Afonso CL; Miller PJ
Dev Comp Immunol; 2013 Nov; 41(3):447-53. PubMed ID: 23623955
[TBL] [Abstract][Full Text] [Related]
19. [Impact of modification of cleavage site of fusion protein and foreign gene insertion on the virulence of Newcastle Disease Virus LaSota vaccine strain].
Wang Y; Ge J; Xie X; Ding Y; Bu Z
Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):362-8. PubMed ID: 18479064
[TBL] [Abstract][Full Text] [Related]
20. Expression of chicken interleukin-2 by a highly virulent strain of Newcastle disease virus leads to decreased systemic viral load but does not significantly affect mortality in chickens.
Susta L; Diel DG; Courtney S; Cardenas-Garcia S; Sundick RS; Miller PJ; Brown CC; Afonso CL
Virol J; 2015 Aug; 12():122. PubMed ID: 26253150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
